Diabetes Care Group, Inc.

Diabetes Care Group, Inc. is a biotechnology and healthcare startup that was founded in 2010 in the United States. The company provides a specialized interdisciplinary model of care for individuals with diabetes, integrating state-of-the-art medical management, patient education, and behavioral modification. This approach aims to improve patient self-management and clinical outcomes, as well as reducing the overall medical and social costs of diabetes. The last investment round, which occurred on 21 May 2012, amounted to $5.00M and was led by Noro-Moseley Partners, Tri-Star Health Partners, Mountain Group Partners, and MedCare Investment Fund. The startup's innovative and documented improvements in outcomes among challenging diabetes patients demonstrate the potential for significant impact in the healthcare industry. Diabetes Care Group's experienced team, comprising board-certified physicians, registered nurse educators, registered dieticians, and medical assistants, is dedicated to empowering diabetes patients to manage their disease effectively. With over a decade of research and clinical experience, the company has established a track record of delivering results for individuals with diabetes, making it an attractive prospect for investment in the biotechnology and healthcare sectors.